Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
absence, acute, administered, adult, antibody, Asacol, assuming, avoid, Azulfidine, back, billion, binding, biologic, BioPharma, biopharmaceutical, biotech, broad, cancer, candidate, capsule, cease, chronic, clinical, companion, Comparison, conducted, Conjupri, consume, consuming, costly, Crohn, crush, crushing, Datamonitor, destruction, diagnostic, diarrhea, difficulty, direct, discomfort, discount, discovery, dispensed, dissolve, dividend, dosage, dose, dosing, dysphagia, easier, easy, eating, efficacy, enhance, exhibited, expand, extreme, FDA, feeding, forecasted, formulation, Fortune, fratricide, frequent, function, high, Humira, immune, immunotherapy, impractical, infection, inflammatory, inventory, juice, killer, Letter, leukemia, LOI, lower, lymphocytic, mAb, maximize, medical, medication, mild, model, monoclonal, monotherapy, multiple, myeloid, myeloma, myriad, NDA, neutralized, NK, notified, optimize, Orphan, owed, Parkinson, passing, patent, PD, pediatric, people, phase, pilot, platform, portion, preliminary, prepay, principle, profile, proprietary, Purple, range, ranging, ready, respiratory, revolutionize, rigidity, satisfy, science, screening, Septermber, shaking, showing, side, simply, solid, Source, stage, Statera, study, successful, suitability, surrender, swallow, swallowing, Symphony, syringe, tablet, Tampa, terminated, termination, therapeutic, tolerate, tool, treatment, Typical, uncontrolled, unnecessary, upper, version, Vici, vitro, vivid, Vycellix
Removed:
extended, meet, organization, registrant, shell, understand
Filing tables
Filing exhibits
COEP similar filings
Filing view
External links
EXHIBIT 32.2
CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
The undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that this Quarterly Report on Form 10-Q for the period ended September 30, 2021 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 15, 2021 | /s/ Christine Sheehy |
Christine Sheehy | |
Chief Financial Officer, and Principal Financial and Accounting Officer |